Physician profile
Bryan Pablo
NPI 1114203239
$4,134.64
in general payments reported to CMS, 2019-2025
13 companies · $41.88 in 2025
The $41.88 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $427 · 2021: $240 · 2022: $3,065 · 2023: $203 · 2024: $158 · 2025: $41.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $403.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,226.03 | 2021-2022 | |
| Celularity INC. | $300.00 | 2019 | |
| Hologic Sales and Service, LLC | $198.93 | 2023-2024 | Aptima, Acessa Provu System |
| Exeltis, USA INC. | $124.98 | 2019-2025 | Slynd |
| Organon LLC | $67.46 | 2022-2024 | Nexplanon |
| Meditrina | $66.18 | 2023 | |
| Davol INC. | $44.95 | 2019 | |
| Evofem Biosciences, INC. | $26.00 | 2022 | |
| Astellas Pharma US INC | $20.53 | 2025 | Veozah |
| Merck Sharp & Dohme LLC | $17.08 | 2019 | |
| Coopersurgical, INC. | $15.29 | 2023 | Paragard T 380a |
| Allergan, INC. | $14.09 | 2019 | |
| Abbvie INC. | $13.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Pablo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.